Valeant Pharmaceuticals Says Philidor Rx Was Not Material, Distances Itself From Liability |
October 27, 2015 | October 2015 Bond Updates |
Valeant's detailed response to a flurry of investor questions shows the lengths the company has gone to carve out legal distance between it and a web of specialty pharmacies, which investors learned just last week were consolidated into its financial statements. |
View more at: http://www.forbes.com/sites/antoinegara/2015/10/26/valeant-pharmaceuticals-says-philidor-rx-was-not-material-distances-itself-from-liability/ |
Related News |